BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7592566)

  • 1. Porphobilinogen deaminase gene structure and molecular defects.
    Deybach JC; Puy H
    J Bioenerg Biomembr; 1995 Apr; 27(2):197-205. PubMed ID: 7592566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
    Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
    Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Schuurmans MM; Schneider-Yin X; Rüfenacht UB; Schnyder C; Minder CE; Puy H; Deybach JC; Minder EI
    Mol Med; 2001 Aug; 7(8):535-42. PubMed ID: 11591889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria.
    Puy H; Gross U; Deybach JC; Robréau AM; Frank M; Nordmann Y; Doss M
    Hum Genet; 1998 Nov; 103(5):570-5. PubMed ID: 9860299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene.
    Astrin KH; Desnick RJ
    Hum Mutat; 1994; 4(4):243-52. PubMed ID: 7866402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation hotspots in the human porphobilinogen deaminase gene: recurrent mutations G111R and R173Q occurring at CpG motifs.
    Schneider-Yin X; Hergersberg M; Schuurmans MM; Gregor A; Minder EI
    J Inherit Metab Dis; 2004; 27(5):625-31. PubMed ID: 15669678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an ancestral founder of the common R116W mutation in the hydroxymethylbilane synthase gene in acute intermittent porphyria in The Netherlands.
    de Rooij FW; Kavelaars FG; Koole-Lesuis H; Wilson JH
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):64-9. PubMed ID: 19656453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.
    Chen CH; Astrin KH; Lee G; Anderson KE; Desnick RJ
    J Clin Invest; 1994 Nov; 94(5):1927-37. PubMed ID: 7962538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a prevalent nonsense mutation (W283X) and two novel mutations in the porphobilinogen deaminase gene of Swiss patients with acute intermittent porphyria.
    Schneider-Yin X; Bogard C; Rüfenacht UB; Puy H; Nordmann Y; Minder EI; Deybach J
    Hum Hered; 2000; 50(4):247-50. PubMed ID: 10782018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms.
    Robreau-Fraolini AM; Puy H; Aquaron C; Bogard C; Traore M; Nordmann Y; Aquaron R; Deybach JC
    Hum Genet; 2000 Aug; 107(2):150-9. PubMed ID: 11030413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population.
    Hrdinka M; Puy H; Martasek P
    Physiol Res; 2006; 55 Suppl 2():S119-136. PubMed ID: 17298216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three new mutations in the porphobilinogen deaminase gene, detected in acute intermittent porphyria patients from Russia].
    Surin VL; Luk'ianenko AV; Karpova IV; Misiurin AV; Pustovot IaS; Pivnik AV
    Genetika; 2001 May; 37(5):690-7. PubMed ID: 11436563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic study of acute intermittent porphyria in Russia: mutation analysis and functional polymorphism search in porphobilinogen deaminase gene].
    Surin VL; Luchinina IuA; Selivanova DS; Pustovoĭt IaS; Karpova IS; Pivnik AV; Luk'ianenko AV; Kravchenko SK
    Genetika; 2010 Apr; 46(4):540-52. PubMed ID: 20536026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRIM-positive mutations of acute intermittent porphyria in Finland.
    Kauppinen R; Peltonen L; Pihlaja H; Mustajoki P
    Hum Mutat; 1992; 1(5):392-6. PubMed ID: 1301948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
    De Siervi A; Rossetti MV; Parera VE; Astrin KH; Aizencang GI; Glass IA; Batlle AM; Desnick RJ
    Am J Med Genet; 1999 Oct; 86(4):366-75. PubMed ID: 10494093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene.
    Kauppinen R; Mustajoki S; Pihlaja H; Peltonen L; Mustajoki P
    Hum Mol Genet; 1995 Feb; 4(2):215-22. PubMed ID: 7757070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
    Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
    Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients.
    Schneider-Yin X; Hergersberg M; Goldgar DE; Rüfenacht UB; Schuurmans MM; Puy H; Deybach JC; Minder EI
    Hum Hered; 2002; 54(2):69-81. PubMed ID: 12566739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute intermittent porphyria: expression of mutant and wild-type porphobilinogen deaminase in COS-1 cells.
    Mustajoki S; Laine M; Lahtela M; Mustajoki P; Peltonen L; Kauppinen R
    Mol Med; 2000 Aug; 6(8):670-9. PubMed ID: 11055586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods.
    Andersson C; Thunell S; Floderus Y; Forsell C; Lundin G; Anvret M; Lannfelt L; Wetterberg L; Lithner F
    J Intern Med; 1995 Mar; 237(3):301-8. PubMed ID: 7891051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.